Effect of dupilumab on allergic contact dermatitis and patch testing-Reference-Cited by-同舟云学术

Effect of dupilumab on allergic contact dermatitis and patch testing

Published:2021-06 Issue:6 Volume:84 Page:1772-1776
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Jo Christine E.,Mufti Asfandyar,Sachdeva Muskaan,Pratt Melanie,Yeung Jensen

Publisher

Elsevier BV

Subject

Dermatology

Reference5 articles.

1. Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response;Dhingra;J Allergy Clin Immunol,2014

2. Both children and adult patients with difficult-to-treat atopic dermatitis have high prevalences of concomitant allergic contact dermatitis and are frequently polysensitized;Boonstra;J Eur Acad Dermatol Venereol,2018

3. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration;Liberati;BMJ,2009

4. Two differing presentations of periocular dermatitis as a side effect of dupilumab for atopic dermatitis;Yamane;Orbit,2019

5. Methodological quality and synthesis of case series and case reports;Murad;BMJ Evid Based Med,2018

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nickel sulphate and thiuram mix allergic contact dermatitis with successful response to dupilumab: Should allergens be immunotyped?;Medical Reports;2024-04

2. A Review of Dupilumab-Induced Adverse Events to Dermatologists and the Potential Pathogenesis in the Treatment of Atopic Dermatitis;Dermatitis®;2024-02-01

3. Patch testing while immunosuppressed: potential risks and benefits;Expert Review of Clinical Immunology;2023-12-23

4. Impact of dupilumab on patch test results and allergic contact dermatitis: A prospective multicenter study;Journal of the American Academy of Dermatology;2023-10

5. Patch Testing in Patients With Severe Atopic Dermatitis Treated With Dupilumab: A Multicentric Approach in Spain;Dermatitis®;2023-08-01